This chart includes past policy and legislative opportunities at the state level.
| State | Year Introduced | Issue | Type (Letter, Regulation Comments, Legislation) | Bill Number & Title | Description | Position Statements & Coalition and Triage Cancer Letter of Support | Status | Learn more | ||
|---|---|---|---|---|---|---|---|---|---|---|
|
California
|
2023 | Insurance Coverage | Legislation | https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=202320240AB236 | AB-236 Health care coverage: provider directories | This bill will eliminate "ghost networks" by enforcing requirements that health insurance companies update their provder directories annually. | Support | https://triagecancer.org/wp-content/uploads/2023/06/TC-Letter-of-Support-CA-AB-236.pdf | Introduced 1/13/2023; amended 2/14/2023, amended 3/20/2023; amended 1/22/2024; referred to committee on Heath 5/1/24last amended 6/27/24 in Senete appropriations as of 12/12/24.) | |
|
California
|
2023 | Insurance Coverage | Legislation | https://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202320240AB4 | AB-4 Covered California; expansion | This bill would allow individuals to purchase health insurance on the Covered California marketplace, regardless of their immigration status | Support | https://triagecancer.org/wp-content/uploads/2023/06/TC-Letter-of-Support-AB-4.pdf | Submitted for Introduction 12/5/2022; amended 3/9/2023; revised 4/12/2023; in committee on appropriations; passed Assembly 5/25/2023; in Senate Committee on Health, amended 6/20 & 6/27; amended 8/6/24 in senate appropriations as of 12/12/24) | |
|
Minnesota
|
2023 | Fertility Preservation | Legislation | https://www.revisor.mn.gov/bills/bill.php?f=HF1658&y=2023&ssn=0&b=house | HF1658 | Coverage requirement for infertility treatment | Support | https://triagecancer.org/wp-content/uploads/2023/06/Triage-Cancer-Letter-of-Suppor-for-MN-HF1658.pdf | ||
|
Ohio
|
2023 | biomarker Testing | Legislation | https://ohiohouse.gov/legislation/135/hb24 | HB 24: to require health benefit plan and Medicaid program coverage of biomarker testing | Require health insurance coverage of Biomarker testing | Support | Introduced 2/15/2023; passed in House, introduced in Senate; 11/12/24 in Senate committee; 12/17/24 still in Senate Committee | ||
|
Washington
|
2023 | Biomarker Testing | Legislation | https://app.leg.wa.gov/billsummary?BillNumber=5074&Year=2023&Initiative=false | SB 5074 (Companion Bill H 1450) | Require that health plans provide coverage for biomarker testing | Support | Reintroduced 1/8/2024 and with Health & Long Term Care Committee; 12/17/24 still in same committee | ||
|
Washington
|
2023 | Fertility Preservation | Legislation | https://app.leg.wa.gov/billsummary?BillNumber=1151&Year=2023&Chamber=House | SHB 1151 Mandating coverage for fertility services | Requires large group health plans, including health plans offered to public employees, to cover the diagnosis of infertility, treatment for infertility, and standard fertility preservation services. | Support - noted support for the legislative record in the Health & Long Term Care Committee | reintroduced 01/8/2024; 2/20/24 - returned to rules committee; 12/17/24 still in rules committee | ||
|
Minnesota
|
2023 | Fertility Preservation | Legislation | https://www.revisor.mn.gov/bills/bill.php?f=SF1704&y=2023&ssn=0&b=senate | SF 1704 | Coverage requirement for infertility treatment | Support | https://triagecancer.org/wp-content/uploads/2023/06/Triage-Cancer-Letter-of-Suppor-for-MN-SF-1704.pdf | Introduced 2/16/2023; Committee recommended to pass as amended 3/8/2023 | |
|
Minnesota
|
2023 | Biomarker Testing | Legislation | https://www.revisor.mn.gov/bills/bill.php?b=Senate&f=SF1948&ssn=0&y=2023 | S1948/HF1978 | Require Health Insurance coverage of Biomarker testing | Support | Introduced 2/20/2023; referred to committee on Commerce and Consumer Protection; Comm report: To pass as amended and re-refer to Health and Human Services | ||
|
Massachussetts
|
2023 | Biomarker Testing | Legislation | https://malegislature.gov/Bills/193/H1074 | HB 1074 | This bill requires that biomarker testing be covered for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an enrollee’s disease or condition when the test is supported by medical and scientific evidence | Support | https://triagecancer.org/wp-content/uploads/2023/06/MA-HB1074-Triage-Cancer-Letter-of-Support.pdf | Introduced 2/16/2023; Committee scheduled hearing 5/2/2023; Reporting date extended to 5/17/2024; Committee recommended bill ought to pass and referred to the committee on House Ways and Means | |
|
Massachussetts
|
2023 | Biomarker Testing | Legislation | https://malegislature.gov/Bills/193/S689 | SB 689 | This bill requires that biomarker testing be covered for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an enrollee’s disease or condition when the test is supported by medical and scientific evidence | Support | https://triagecancer.org/wp-content/uploads/2023/06/MA-SB689-Triage-Cancer-Letter-of-Support.pdf | Introduced 2/16/2023; Committee scheduled hearing 5/2/2023; Reporting date extended to 5/17/2024; 6/20/24 Accompanied H1074 | |
|
Illinois
|
2023 | Paid Leave | Legislation | https://www.ilga.gov/legislation/billstatus.asp?DocNum=1530&GAID=17&GA=103&DocTypeID=HB&LegID=143835&SessionID=112 | HB 1530 | The Family and Medical Leave Insurance Act creates a state-run insurance program that allows Illinois workers to use up to 26 weeks of job-protected leave a year: | support | https://www.iltimetocare.org/home | Introduced 1/27/2023; 1/31/2023 referred to Rules Committee; 3/8/2023 To Job Growth & Workforce Development Subcommittee; 3/10/2023 Rule 19(a) / Re-referred to Rules Committee | |
|
Illinois
|
2023 | Paid Leave | Legislation | https://www.ilga.gov/legislation/BillStatus.asp?DocNum=1234&GAID=17&DocTypeID=SB&SessionID=112&GA=103 | SB 1234 | The Family and Medical Leave Insurance Act creates a state-run insurance program that allows Illinois workers to use up to 26 weeks of job-protected leave a year: | support | https://www.iltimetocare.org/home | Introduced 2/2/2023, sent to Labor Committee, 3/10/2023 Rule 3-9(a) / Re-referred to Assignments | |
|
Illinois
|
2023 | Paid Family Leave | Legislation | https://www.ilga.gov/legislation/BillStatus.asp?DocNum=1006&GAID=17&DocTypeID=HB&SessionID=112&GA=103 | HB1006 Paid Family Leave Act | Require employers to provide 6 weeks of paid leave to provide care for a family member | Support | Introduced 1/12/2023; referred to Rules Committee | ||
|
Texas
|
2023 | Biomarker Testing | Legislation | https://capitol.texas.gov/BillLookup/Actions.aspx?LegSess=88R&Bill=HB3188 | HB3188: Relating to health benefit plan coverage for certain biomarker testing | Require health insurance coverage of Biomarker testing | Support | https://triagecancer.org/wp-content/uploads/2023/06/TX-SB989-partner-letter_final.pdf | Filed 3/1/2023; 4/18/23 pending in committee; 12/17/24 still pending in committee so moving to past issues. | |
|
California
|
2022 | Access to Cancer Treatment for Medi-Cal beneficiaries | Bill | https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=202120220SB987 | SB 987- Cancer Care Equity Act | The California Cancer Care Equity Act would ensure Medi-Cal beneficiaries who receive a complex cancer diagnosis have the choice to seek treatment at a comprehensive cancer center, increasing the number of Californians able to benefit from emerging therapies, clinical trials and appropriate cancer treatment specialized for particular types of cancer. | Support | https://triagecancer.org/wp-content/uploads/2022/05/SB-987-Cancer-Coalition-Support.pdf | Signed in to law on 9/27/2022 | |
|
California
|
2022 | Biomarker Testing | Bill | SB 912 | Senate Bill 912 will require state-regulated plans, including Medi-Cal, to cover comprehensive biomarker testing when supported by medical and scientific evidence, including nationally recognized clinical practice guidelines. | Support | https://triaghttps://triagecancer.org/wp-content/uploads/2022/09/TC-Support-for-SB912.pdf | Vetoed by Governor on 9/29/2022 | ||
|
California
|
2021 | Health Insurance Coverage for Biomarker Testing | Bill | https://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202120220SB535 | SB 535 | By requiring California health care plans to cover biomarker testing, this bill facilitates patient access to testing and reduces associated costs. This legislation will further protect patients’ access to care by prohibiting plans from requiring preauthorization for these services, eliminating pre-authorization for biomarker testing for patients with advanced or metastatic cancers. | Support | https://triagecancer.org/CA-SB-535-Letter-of-Support | Passed both chambers, signed into law on 10/6/2021 | |
|
California
|
2021 | Cancer Medication Recycling Act | Bill | https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=202120220SB310 | SB-310 - The Cancer Medication Recycling Act | This legislation would facilitate patient access to oral cancer medications by creating an avenue for providers to donate unused medications to patients in need, increasing the likelihood that patients will correctly administer these life-saving medications. | Support | https://triagecancer.org/CA-SB-310-Letter-of-Support | Signed into law on 10/5/2021 | |
|
California
|
2021 | Health Insurance Coverage for Colorectal Cancer Testing | Bill | https://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202120220AB342 | AB 342 | This legislation would facilitate patient access to colorectal cancer (CRC) testing by requiring insurance companies and health plans to provide coverage for follow-up tests without cost-sharing, reducing out-of-pocket medical costs and increasingly the likelihood that patients will proactively undergo follow up testing, rather than decline crucial testing due to costs. | Support | https://triagecancer.org/CA-AB-342-Letter-of-Support | Signed into law on 10/1/2021 | |
|
Colorado
|
2023 | Biomarker Testing | Legislation | https://leg.colorado.gov/bills/hb23-1110 | H23-1110 | Require health insurance coverage of Biomarker Testing | Support | Lost 5/11/23 | ||
|
Connecticut
|
2023 | Biomarker Testing | Legislation | https://cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&which_year=2023&bill_num=976 | SB 976 AN ACT CONCERNING HEALTH COVERAGE MANDATES FOR CERTAIN HEALTH CONDITIONS | Require Commercial Health Insurance plans to cover biomarker testing. | Support | Died in committee | ||
|
Connecticut
|
2023 | Biomarker Testing | Legislation | https://cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&which_year=2023&bill_num=6628 | HB 6628 AN ACT CONCERNING MEDICAID COVERAGE OF BIOMARKER TESTING | Require Medicaid to cover Biomarker Testing | Support | Died in committee | ||
|
Florida
|
2023 | Biomarker Testing | Legislation | https://www.flsenate.gov/Session/Bill/2023/805 | HB 805: Health Insurance Coverage for Biomarker Testing | Require Health Insurance coverage of Biomarker Testing | Support | 5/5/2023 - Action Died | ||
|
Florida
|
2023 | Biomarker Testing | Legislation | https://www.flsenate.gov/Session/Bill/2023/1218/ByCategory | SB 1218: Biomarker Testing | Require Medicaid to cover Biomarker Testing | Support | 5/5/2023 - Action Died | ||
|
Louisiana
|
2021 | Health Insurance Coverage for Genetic Testing | Bill | http://www.legis.la.gov/Legis/BillInfo.aspx?i=240103 | LA SB 84 | This act facilitates cancer patients' access to genetic testing by requiring health plans to provide coverage for these services. | Support | https://triagecancer.org/LA-SB-84-Letter-of-Support | Effective date 1/1/2022 | |
|
Maine
|
2023 | Biomarker Testing | Legislation | https://legislature.maine.gov/LawMakerWeb/dockets.asp?ID=280088559 | LD 1577: An Act to Require Health Insurance Coverage for Biomarker Testing | This bill requires that biomarker testing be covered for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an enrollee’s disease or condition when the test is supported by medical and scientific evidence | Support | https://triagecancer.org/wp-content/uploads/2023/06/ME-LD-1577-Triage-Cancer-Letter-of-Support.pdf | Passed by House and Senate 5/10/24; waiting enactment. Governor announced that she will not be signing any bills due to legality of legislative work after adjournment. | |
|
Maine
|
2023 | Paid Family and Medical Leave | Legislation | https://legislature.maine.gov/bills/display_ps.asp?paper=SP0800&snum=131&PID=0 | LD 1964 An Act to Implement the Recommendations of the Commission to Develop a Paid Family and Medical Leave Benefits Program | Create a Paid Family and Medical Leave program for Maine workers. | Support | https://triagecancer.org/wp-content/uploads/2023/05/Triage-Cancer-Support-for-Maine-LD-1964.pdf | Died on Adjournment 7/26/2023 | |
|
Minnesota
|
2022 | Biomarker Testing | bill | https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF4899&ssn=0&y=2022 | HF4899/SF4610 | Health plans required to provide coverage for biomarker testing. | Support | No action taken | ||
|
New Jersey
|
2021 | State Guidelines for Step Therapy Protocols | Bill | https://www.njleg.state.nj.us/bill-search/2020/A4815 | S3051/A4815 Establishes certain guidelines for health insurance carriers concerning step therapy protocols. | This act would ensure patient access to appropriate care by requiring health insurance carriers to base step therapy protocols on peer-reviewed data, exempting patients from step therapy when protocols would not be in the best interest of the patient, and establishing patients' right to a fair process for requesting exemptions. | Support | Passed by House, died in Senate Commerce Committee | ||
|
New York
|
2022 | Biomarker Testing | Bill | https://assembly.state.ny.us/leg/?default_fld=&leg_video=&bn=A09149&term=2021&Summary=Y | A09149 | Assembly Bill A09149 will require increased coverage of Biomarker Testing for those on both public and private health insurance plans. Despite the clear benefits of biomarker testing, many insurance plans do not cover evidence-based biomarker testing for all patients who need it. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. | Support | https://triagecancer.org/wp-content/uploads/2022/06/NCOIL-biomarker-coalition-letter_FINAL.pdf | Died in insurance committee | |
|
New York
|
2020 | Paid Sick Leave for New Yorkers | Bill | https://www.nysenate.gov/legislation/bills/2019/a9506 | New York Assembly Bill A9506B | Building on protections created during the COVID-19 pandemic, this bill guarantees most New York residents one hour of paid sick leave for every 30 hours worked. | Support | Signed by the Governor 04/03/2021, effective 01/01/2021 | ||
|
North Carolina
|
2021 | Medicaid Expasion | Bill | https://lrs.sog.unc.edu/bill-summaries-lookup/H/149/2021/H149 | H149 Will expand access to eligible adults up to 138% of the Federal Poverty Level | This bill would allow adults who do not qualify under another program to enroll in Medicaid if their income is below 138% of poverty. NC expects that about 600,000 low income individuals would become eligible under expansion criteria. | Support | https://triagecancer.org/wp-content/uploads/2022/09/Triage-Cancer-Support-for-HB-149.pdf | Passed the Senate (6/2/2022), Returned to House, no further action taken | |
|
Ohio
|
2021 | Enact Vaccine Choice and Anti-Discrimination Act | Bill | https://www.legislature.ohio.gov/legislation/legislation-summary?id=GA134-HB-248 | HB 248-11 Enact Vaccine Choice and Anti-Discrimination Act | The legislature has heard that this bill’s purpose is to prevent the COVID-19 vaccine from becoming mandatory, but HB 248-11 applies to ALL immunizations, including childhood vaccines. If passed, this legislation has the potential to reverse decades of immunity from life-threatening, but vaccine-preventable diseases such as measles, mumps, hepatitis, meningitis and polio. | Oppose | https://triagecancer.org/Vaccine-Coalition-Letter_6.14 | Died in the House Health Committee | |
|
Pennsylvania
|
2022 | The MRI Bill | Bill | https://www.legis.state.pa.us/cfdocs/billInfo/BillInfo.cfm?syear=2021&sind=0&body=S&type=B&bn=1225 | S1225 | This will clarify that the MRI/Ultrasound coverage extends to women with any of the following risk factors, and without the application of any deductible, copayment or coinsurance provisions contained in the policy or plan:personal history of atypical breast histologies;personal history or family history of breast cancer;genetic predisposition for breast cancer;prior therapeutic thoracic radiation therapy;extremely dense or heterogeneously dense breast tissue based on breast composition categories of the Breast Imaging and Reporting Data System established by the American College of Radiology. | Support | Passed by the Senate, referred to the House Insurance committee, no further action taken |